Literature DB >> 25014044

Diabetes mellitus may induce cardiovascular disease by decreasing neuroplasticity.

Zhihua Zheng, Junyan Wu, Ruolun Wang, Yingtong Zeng.   

Abstract

Neuroplasticity has been defined "the ability of the nervous system to respond to intrinsic or extrinsic stimuli by reorganizing its structure, function and connections". The nervous system monitors and coordinates internal organ function. Thus neuroplasticity may be associated with the pathogenesis of other diseases besides neuropsychiatric diseases. Decreased neuroplasticity is associated with cardiovascular disease (CVD) and a disease related to decreased neuroplasticity may confer a greater CVD risk. Diabetes mellitus (DM) is related to CVD and DM induces decreased neuroplasticity, which is manifested as depression, Alzheimer's disease and diabetic neuropathy. Therefore we conclude that DM may induce CVD by decreasing neuroplasticity.

Entities:  

Mesh:

Year:  2014        PMID: 25014044      PMCID: PMC4172250     

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  91 in total

Review 1.  Management of coronary artery disease: therapeutic options in patients with diabetes.

Authors:  T Hammoud; J F Tanguay; M G Bourassa
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

2.  Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.

Authors:  L Wang; M Chopp; A Szalad; Z Liu; M Bolz; F M Alvarez; M Lu; L Zhang; Y Cui; R L Zhang; Z G Zhang
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

3.  Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model.

Authors:  Anthony Brureau; Charleine Zussy; Brice Delair; Charline Ogier; Guy Ixart; Tangui Maurice; Laurent Givalois
Journal:  Neurobiol Aging       Date:  2012-12-27       Impact factor: 4.673

Review 4.  Current options and perspectives in the treatment of diabetic neuropathy.

Authors:  Tamás Várkonyi; Zsuzsanna Putz; Katalin Keresztes; Tímea Martos; Csaba Lengyel; Alin Stirban; György Jermendy; Peter Kempler
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

5.  Increased neuroplasticity may protect against cardiovascular disease.

Authors:  Zhihua Zheng; Yingtong Zeng; Junyan Wu
Journal:  Int J Neurosci       Date:  2013-04-26       Impact factor: 2.292

6.  Depressed mood is a factor in glycemic control in type 1 diabetes.

Authors:  M A Van Tilburg; C C McCaskill; J D Lane; C L Edwards; A Bethel; M N Feinglos; R S Surwit
Journal:  Psychosom Med       Date:  2001 Jul-Aug       Impact factor: 4.312

7.  Association of depression and diabetes complications: a meta-analysis.

Authors:  M de Groot; R Anderson; K E Freedland; R E Clouse; P J Lustman
Journal:  Psychosom Med       Date:  2001 Jul-Aug       Impact factor: 4.312

8.  Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.

Authors:  Elizabeth Selvin; Spyridon Marinopoulos; Gail Berkenblit; Tejal Rami; Frederick L Brancati; Neil R Powe; Sherita Hill Golden
Journal:  Ann Intern Med       Date:  2004-09-21       Impact factor: 25.391

9.  Impaired cardiovagal and vasomotor responses to baroreceptor stimulation in type II diabetes mellitus.

Authors:  E O Sanya; C M Brown; M Dütsch; U Zikeli; B Neundörfer; M J Hilz
Journal:  Eur J Clin Invest       Date:  2003-07       Impact factor: 4.686

10.  Intranasal insulin prevents cognitive decline, cerebral atrophy and white matter changes in murine type I diabetic encephalopathy.

Authors:  George J Francis; Jose A Martinez; Wei Q Liu; Kevin Xu; Amit Ayer; Jared Fine; Ursula I Tuor; Gordon Glazner; Leah R Hanson; William H Frey; Cory Toth
Journal:  Brain       Date:  2008-11-16       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.